Document Detail


Elevated uric acid and functional mitral regurgitation in dilated cardiomyopathy.
MedLine Citation:
PMID:  23161034     Owner:  NLM     Status:  MEDLINE    
Abstract/OtherAbstract:
BACKGROUND: Recent findings suggest that there is a close relationship between chronic heart failure and uric acid.
AIMS: The aim of the study was to assess whether increased uric acid levels in patients with dilated cardiomyopathy might correlate with the degree of functional mitral regurgitation (MR).
MATERIALS AND METHODS: Sixty two consecutive patients diagnosed with dilated cardiomyopathy were included in the study. The patients were classified according to severity of functional MR into two groups: mild-moderate functional MR (ERO < 0.2 cm2) and severe functional MR.
RESULTS: The patients with severe functional MR had significantly higher serum uric acid levels compared to patients without severe functional MR (6.34 ± 1.61 mg/dL vs 5.43 ± 1.17 mg/dL respectively, p = 0.012). Furthermore, tenting area, an important predictor of functional MR severity, was moderately correlated with the serum uric acid levels (r = 0.351, p = 0.005). It was also shown that the serum uric acid concentrations were inversely correlated with left ventricular (LV) ejection fraction, and positively correlated with LV volumes. There was also a significant relation between the serum uric acid and left atrial volumes and also brain natriuretic peptide (BNP) levels.
CONCLUSIONS: In conclusion, this study demonstrates that elevated serum uric acid levels in patients with dilated cardiomyopathy are correlated with the severity of functional MR and echocardiographic volume indices.
Authors:
M V Yazicioğlu; A Avci; G Açar; Ö Esen; O Karaca; G Alici; B Özkan; E Alizade; M Bulut; M Akçakoyun; A M Esen
Related Documents :
9458184 - Biotransformation, excretion and nephrotoxicity of haloalkene-derived cysteine s-conjug...
22704134 - Antimicrobial activity of lactic acid bacteria against listeria monocytogenes on frankf...
11282094 - Urine 4-heptanone: a beta-oxidation product of 2-ethylhexanoic acid from plasticisers.
1496824 - Biotransformation of diethenylbenzenes. iii: identification of metabolites of 1,3-dieth...
12798104 - Short-term tests with a pilot sewage plant and biofilm reactors for the biological degr...
19857924 - Characterization of acid tars.
Publication Detail:
Type:  Journal Article    
Journal Detail:
Title:  European review for medical and pharmacological sciences     Volume:  16     ISSN:  1128-3602     ISO Abbreviation:  Eur Rev Med Pharmacol Sci     Publication Date:  2012 Nov 
Date Detail:
Created Date:  2012-11-19     Completed Date:  2013-01-22     Revised Date:  2013-02-07    
Medline Journal Info:
Nlm Unique ID:  9717360     Medline TA:  Eur Rev Med Pharmacol Sci     Country:  Italy    
Other Details:
Languages:  eng     Pagination:  1637-41     Citation Subset:  IM    
Affiliation:
Department of Cardiology, Kartal Kosuyolu Yuksek Ihtisas Heart-Education and Research Hospital, Istanbul, Turkey.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Descriptor/Qualifier:
Adult
Biological Markers / blood
Cardiomyopathy, Dilated / blood*,  complications
Echocardiography / methods,  statistics & numerical data
Female
Humans
Male
Middle Aged
Mitral Valve Insufficiency / blood*,  complications
Natriuretic Peptide, Brain / metabolism
Severity of Illness Index
Uric Acid / metabolism*
Chemical
Reg. No./Substance:
0/Biological Markers; 114471-18-0/Natriuretic Peptide, Brain; 69-93-2/Uric Acid

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine


Previous Document:  The patient with chronic ischemic heart disease. Role of ranolazine in the management of stable angi...
Next Document:  Same effect of sublingual and oral captopril in hypertensive crisis.